APA (7th ed.) Citation

SC, K., E, Z., C, C., AB, T., M, B., JS, S., . . . EP, S. (2024). Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma. Clinical cancer research : an official journal of the American Association for Cancer Research, 30(4), 680. https://doi.org/10.1158/1078-0432.CCR-23-2533

Chicago Style (17th ed.) Citation

SC, Kurz, et al. "Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 30, no. 4 (2024): 680. https://doi.org/10.1158/1078-0432.CCR-23-2533.

MLA (9th ed.) Citation

SC, Kurz, et al. "Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 30, no. 4, 2024, p. 680, https://doi.org/10.1158/1078-0432.CCR-23-2533.